| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |